About Conference

Welcome to the 38th Conference on Preventive Oncology and Diagnostic Cancer, scheduled for May 05-06, 2025, in the beautiful city of Rome, Italy. Preventive Oncology Conference will gather global experts in the fields of oncology, diagnostics, and cancer prevention to discuss innovations and breakthroughs aimed at reducing cancer incidence worldwide. The conference will provide an interdisciplinary platform for scientists, healthcare professionals, industry leaders, and students to share their expertise and collaborate on the most pressing issues in oncology today.

Conference Theme: "Innovative Approaches in Cancer Prevention and Early Diagnosis: Pioneering the Future of Oncology"

The theme of Preventive Oncology 2025 focuses on the critical role of early detection, cutting-edge diagnostic technologies, and preventive strategies in reducing cancer mortality. As cancer remains one of the leading causes of death worldwide, this event aims to foster collaboration and knowledge exchange to drive advancements in prevention and diagnostics, ultimately improving patient outcomes and global health.

Abstract Submission is now open, and we invite researchers and professionals to contribute their latest findings. Early submissions will benefit from reduced registration fees and prioritized presentation opportunities. Ensure to register early to secure your spot at this groundbreaking event!

Why Attend?

The 38th Conference on Preventive Oncology and Diagnostic Cancer provides a unique opportunity to:

• Engage with Global Experts: Hear from leading oncologists, researchers, and healthcare practitioners who are driving innovations in cancer prevention and diagnostics.
• Stay Ahead of Trends: Learn about the latest research, cutting-edge technologies, and clinical practices that are shaping the future of oncology.
• Build Your Network: Interact with professionals and thought leaders from around the world, fostering potential collaborations and partnerships.
• Present Your Work: Showcase your research findings to a global audience and receive valuable feedback from peers and experts in the field.
• Discover Rome: Experience the rich history, culture, and cuisine of Rome while attending a world-class scientific event.

Who Can Attend?

This conference welcomes participants from a wide range of professions, including:

• Oncologists and Hematologists
• Cancer Researchers and Scientists
• Pathologists and Diagnostic Specialists
• Radiologists and Imaging Experts
• Epidemiologists and Public Health Professionals
• Healthcare Providers and Clinicians
• Pharmaceutical and Biotech Professionals
• Medical Device Manufacturers
• Graduate and Postgraduate Students
• Cancer Advocacy Groups
• Medical Directors and Healthcare Administrators

Scientific Sessions

Track 16. PET Scans in High-Risk Populations for Cancer Prevention

Participation Benefits

Attendees of the 38th Conference on Preventive Oncology and Diagnostic Cancer will enjoy a variety of exclusive benefits, including:

• Certification of Participation to recognize your involvement in the conference.
• Access to All Scientific Sessions and interactive workshops.
• Opportunities to Present Research and receive feedback from leading experts in oncology.
• Networking Opportunities with top professionals, researchers, and organizations in the field.
• Published Abstracts in indexed scientific journals, offering global exposure for your work.
• Exclusive Conference Kit including materials and resources.
• Award Eligibility for the best presentations, posters, and research contributions.

Global Associations, Societies & Universities

Top 20 Global Associates:

1. American Association for Cancer Research (AACR) - aacr.org
2. American Society of Clinical Oncology (ASCO) - asco.org
3. European Society for Medical Oncology (ESMO) - esmo.org
4. International Agency for Research on Cancer (IARC) - iarc.fr
5. World Health Organization (WHO) - who.int
6. National Cancer Institute (NCI) - cancer.gov
7. International Union Against Cancer (UICC) - uicc.org
8. Cancer Research UK - cancerresearchuk.org
9. American Cancer Society (ACS) - cancer.org
10. European Association for Cancer Research (EACR) - eacr.org
11. Canadian Cancer Society - cancer.ca
12. Asian Pacific Organization for Cancer Prevention (APOCP) - apocp.org
13. Australasian Society for Breast Disease (ASBD) - asbd.org.au
14. Union for International Cancer Control (UICC) - uicc.org
15. Oncology Nursing Society (ONS) - ons.org
16. Japanese Cancer Association (JCA) - jca.gr.jp
17. Society of Surgical Oncology (SSO) - surgonc.org
18. National Comprehensive Cancer Network (NCCN) - nccn.org
19. Society for Immunotherapy of Cancer (SITC) - sitcancer.org
20. European Cancer Organisation (ECCO) - europeancancer.org

Top 20 Societies:

1. American Society of Preventive Oncology (ASPO) - aspo.org
2. European Society for Preventive Oncology (ESPO) - espo.eu.com
3. International Society for Preventive Oncology (ISPO) - cancerprev.org
4. Society for Cancer Prevention (SCP) - socprev.org
5. Prevent Cancer Foundation - preventcancer.org
6. British Society for Immunology - immunology.org
7. Society for Integrative Oncology (SIO) - integrativeonc.org
8. Association of Community Cancer Centers (ACCC) - accc-cancer.org
9. European Society of Breast Cancer Specialists (EUSOMA) - eusoma.org
10. National Society of Genetic Counselors (NSGC) - nsgc.org
11. International Psycho-Oncology Society (IPOS) - ipos-society.org
12. Oncology Nursing Society (ONS) - ons.org
13. International Association for the Study of Lung Cancer (IASLC) - iaslc.org
14. American Radium Society (ARS) - americanradiumsociety.org
15. European Society of Gynecological Oncology (ESGO) - esgo.org
16. European Oncology Nursing Society (EONS) - cancernurse.eu
17. Society for Translational Oncology (STO) - sto-online.org
18. Association of European Cancer Leagues (ECL) - europeancancerleagues.org
19. World Federation of Surgical Oncology Societies (WFSOS) - wfsos.org
20. International Society for Pediatric Oncology (SIOP) - siop-online.org

Top 20 Universities:

1. Harvard University - harvard.edu
2. University of Oxford - ox.ac.uk
3. Stanford University - stanford.edu
4. University of Cambridge - cam.ac.uk
5. Johns Hopkins University - jhu.edu
6. Massachusetts Institute of Technology (MIT) - mit.edu
7. University of California, San Francisco (UCSF) - ucsf.edu
8. University of California, Los Angeles (UCLA) - ucla.edu
9. University of Toronto - utoronto.ca
10. Karolinska Institute - ki.se
11. Imperial College London - imperial.ac.uk
12. University of Sydney - sydney.edu.au
13. University of Melbourne - unimelb.edu.au
14. National University of Singapore (NUS) - nus.edu.sg
15. University of Tokyo - u-tokyo.ac.jp
16. University of Pennsylvania (Penn) - upenn.edu
17. University of Chicago - uchicago.edu
18. Yale University - yale.edu
19. University of Michigan - umich.edu
20. University of Washington - washington.edu

Market Analysis

The global cancer diagnostics market is projected to reach USD 106.24 billion by 2024 and grow to USD 156.97 billion by 2029, with a compound annual growth rate (CAGR) of 8.12% during this period.

The COVID-19 pandemic significantly impacted the industry, leading to a sharp decline in cancer diagnostics, particularly in colorectal cancer screenings, where referrals dropped by 31% during the first wave. Endoscopic diagnostic procedures were halted to prevent virus transmission, causing delays in cancer care. However, post-pandemic, the market has recovered, with diagnostic procedures returning to pre-pandemic levels. The market is expected to grow robustly with the easing of restrictions.

Several key factors are driving this expansion:

• Rising global cancer prevalence: The global cancer burden continues to increase, with an aging population contributing significantly to this rise. In 2022, approximately 233,900 Canadians were living with cancer, and by 2040, the number of cancer cases worldwide is projected to exceed 30 million, according to Globocan.

• Advancements in diagnostic technologies: Innovations such as biomarkers, liquid biopsies, and point-of-care testing have improved early detection, precision, and accessibility, further propelling market growth.